Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck Serono and Bristol-Myers Squibb to promote Glucophage in China

March 20, 2013

Boehringer Ingelheim and Lilly commence MARLINA trial

March 20, 2013

Alnylam begins phase I ALN-TTRsc trial in TTR-mediated amyloidosis

March 19, 2013

Novo Nordisk reports data from phase IIIa liraglutide study

March 19, 2013

Trimel reports pivotal phase III data for CompleoTRT

March 19, 2013

Hyperuricemia therapy patented by Kissei Pharmaceutical

March 19, 2013

Novel CETP inhibitors patented at Merck & Co.

March 18, 2013

FDA reviewing possible safety risk associated with incretin mimetic drugs for type 2 diabetes

March 15, 2013

Novel Chinese yam-derived protein patented for menopause and osteoporosis

March 15, 2013

Astellas files for Japanese approval of ipragliflozin

March 14, 2013

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...